FNMA Drops As Keefe Bruyette Slashes Price Target

Federal National Mortgage Association stocks have been trading down by -7.5 percent amid mounting concerns over housing market stability.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading FNMA

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Keefe Bruyette cut its price target on Fannie Mae common shares to $3.50 from $6.25, signaling a sharply lower view on FNMA.
The firm kept an Underperform rating on FNMA even while expecting robust earnings at both Fannie Mae and Freddie Mac.
Uncertainty around privatization remains a core overhang on FNMA’s long‑term equity story.
Keefe Bruyette flagged potential heavy dilution from conversion of senior preferred shares as a key risk for Fannie Mae traders.

Live Update At 12:33:43 EDT: On Tuesday, September 29, 2026 Federal National Mortgage Association stock [NASDAQ: FNMA] is trending down by -7.5%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

FNMA looks like a classic case where the chart and the fundamentals are pulling in opposite directions. On the one hand, Federal National Mortgage Association just printed solid numbers. Revenue runs around $29.16B, with profit margins north of 50% on a continuing basis and a pretax margin of about 69.5%. That is massive earning power for FNMA, even in a tricky housing and rate environment.

Valuation is cheap on paper. FNMA trades at a price‑to‑earnings ratio near 6.7 and a price‑to‑sales ratio around 0.19. The stock also changes hands at roughly 0.06 times book value, with book value per share over $84. For most normal companies, that kind of discount would scream value.

More Breaking News

But FNMA is not a normal company. The balance sheet shows more than $4.16T in long‑term debt and leverage above 44. Capital structure and government control matter more than simple ratios. On the tape, FNMA has slid from the $6 area earlier this month down toward $4.06, with a sequence of lower highs and heavy selling pressure. Intraday action shows fading bounces and tight consolidations, signaling that short‑term momentum is firmly on the downside.

Why Traders Are Watching FNMA After The Target Cut

FNMA is back in the spotlight after Keefe Bruyette slashed its price target to $3.50 from $6.25 and reinforced an Underperform rating. That kind of reset matters. When a street firm cuts its target on Fannie Mae common shares almost in half, traders pay attention, especially after the stock has already dropped from about $6 to near $4.

The message from Keefe Bruyette is blunt. Even with expectations for robust earnings at both Fannie Mae and Freddie Mac, the common stock of FNMA faces big structural risks. The first is privatization. Traders have waited years for clarity on when and how FNMA might exit government control. The note underlines that this path remains cloudy, which keeps a lid on how high the equity can justify trading.

The second is dilution. Keefe Bruyette highlighted the danger that senior preferred shares could convert and heavily dilute common holders. For day traders, that is not a tomorrow headline, but it shapes the narrative that big money uses to price FNMA. As long as that dilution overhang sticks, every bounce on the chart is suspect.

You can see that in the recent price action. FNMA tried to hold the mid‑$5s, then cracked, then failed again around $4.70–$4.80. Each lower high lines up with the idea that smart money is selling strength. For active traders, that usually means respecting the trend, not fighting it, and treating FNMA as a short‑biased or quick‑scalp name until the story shifts.

Conclusion

FNMA sits at one of those crossroads that experienced traders know well. On the surface, Fannie Mae produces strong earnings, throws off solid cash flow, and looks dirt cheap on income and book multiples. Underneath, the Keefe Bruyette call reminds the market that policy risk and capital‑structure risk can crush any simple value case in this stock.

For traders, that tension is the whole game. FNMA’s recent slide from around $6 to close to $4.06 shows how fast sentiment can reset when Wall Street leans bearish. The Keefe Bruyette price target cut to $3.50, plus the Underperform rating, tells you that many desks will now frame rallies in Fannie Mae as selling opportunities until there is real progress on privatization and dilution clarity.

That does not mean FNMA is untradeable. It means you treat it as a catalyst‑driven, headline‑sensitive vehicle. Map the key levels, watch liquidity, and do not marry a bias. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your risk management.” In the same spirit, and as a practical trading reminder, As Tim Bohen, lead trainer with StocksToTrade says, “I focus on what a stock is doing, not what I want it to do. Let the stock prove itself before you make a move.”. With FNMA, that means cutting losses fast, respecting the downtrend, and letting the chart tell you when the crowd finally starts to price in more than just fear.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!